Editorial: is sofosbuvir-based therapy suitable for patients with advanced chronic kidney disease?

Aliment Pharmacol Ther. 2018 Aug;48(3):379-380. doi: 10.1111/apt.14831.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 2-Naphthylamine
  • Anilides
  • Benzimidazoles
  • Carbamates
  • Cyclopropanes
  • Fluorenes
  • Humans
  • Lactams, Macrocyclic
  • Macrocyclic Compounds
  • Proline / analogs & derivatives
  • Renal Insufficiency, Chronic*
  • Ritonavir
  • Sofosbuvir*
  • Sulfonamides
  • Treatment Outcome
  • Uracil / analogs & derivatives
  • Valine

Substances

  • Anilides
  • Benzimidazoles
  • Carbamates
  • Cyclopropanes
  • Fluorenes
  • Lactams, Macrocyclic
  • Macrocyclic Compounds
  • Sulfonamides
  • ledipasvir
  • ombitasvir
  • Uracil
  • Proline
  • 2-Naphthylamine
  • dasabuvir
  • Valine
  • Ritonavir
  • paritaprevir
  • Sofosbuvir